Class 3 Medicines Recall: Accord Healthcare Limited, Irinotecan Hydrochloride Concentrate for Solution for Infusion 20mg/ml (5ml vial) EL (20)A/33

Accord Healthcare Limited has informed MHRA it is recalling a batch as a precautionary measure, due to the observation of precipitation in the solution in the same batch marketed in another country (Malta). No complaints or adverse reaction reports have been received by the company to date for the UK product.

Further information, including the affected batch and advice for health professionals is available on the MHRA website.